In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors
- PMID: 12088725
- DOI: 10.1016/s0969-8051(02)00314-1
In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors
Abstract
A new radiolabeled bombesin analogue, [99mTc(I)-PADA-AVA]bombesin (7-14), was synthesized and in vitro and in vivo characterized. High affinity and rapid internalization were obtained in binding assays. A specific binding towards gastrin releasing peptide receptors-positive tissues, pancreas and tumor, was observed in CD-1 nu/nu mice bearing PC-3 prostate adenocarcinoma xenografts. We therefore conclude that [99mTc(I)-PADA-AVA]bombesin (7-14) might have promising characteristics for applications in nuclear medicine, namely for diagnosis of GRP receptor overexpressing tumors.
Similar articles
-
New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.Q J Nucl Med Mol Imaging. 2007 Mar;51(1):42-50. Q J Nucl Med Mol Imaging. 2007. PMID: 17372572
-
Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.Nucl Med Commun. 2006 Apr;27(4):371-6. doi: 10.1097/01.mnm.0000202863.52046.7f. Nucl Med Commun. 2006. PMID: 16531924
-
Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.Nucl Med Biol. 2013 Nov;40(8):1025-34. doi: 10.1016/j.nucmedbio.2013.07.005. Epub 2013 Aug 19. Nucl Med Biol. 2013. PMID: 23969085
-
Bombesin-Targeted PET of Prostate Cancer.J Nucl Med. 2016 Oct;57(Suppl 3):67S-72S. doi: 10.2967/jnumed.115.170977. J Nucl Med. 2016. PMID: 27694175 Review.
-
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.Nucl Med Biol. 2003 Nov;30(8):861-8. doi: 10.1016/s0969-8051(03)00116-1. Nucl Med Biol. 2003. PMID: 14698790 Review.
Cited by
-
Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.Small. 2011 Jun 20;7(12):1664-72. doi: 10.1002/smll.201000435. Epub 2011 Apr 26. Small. 2011. PMID: 21520408 Free PMC article.
-
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.Adv Drug Deliv Rev. 2008 Sep;60(12):1347-70. doi: 10.1016/j.addr.2008.04.006. Epub 2008 Apr 23. Adv Drug Deliv Rev. 2008. PMID: 18538888 Free PMC article. Review.
-
Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.Front Chem. 2020 Jul 7;8:571. doi: 10.3389/fchem.2020.00571. eCollection 2020. Front Chem. 2020. PMID: 32733853 Free PMC article. Review.
-
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1228-38. doi: 10.1007/s00259-006-0356-3. Epub 2007 Feb 8. Eur J Nucl Med Mol Imaging. 2007. PMID: 17287960
-
Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imaging.Invest New Drugs. 2014 Feb;32(1):37-46. doi: 10.1007/s10637-013-9975-2. Epub 2013 Jun 1. Invest New Drugs. 2014. PMID: 23728918
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials